Doyle Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$16.5M Sell
191,071
-1,196
-0.6% -$107K 1.41% 22
2022
Q2
$17.5M Sell
192,267
-2,297
-1% -$204K 1.41% 24
2022
Q1
$16M Buy
194,564
+4,070
+2% +$321K 1.15% 34
2021
Q4
$14.6M Buy
190,494
+4,955
+3% +$395K 1.05% 38
2021
Q3
$13.9M Buy
185,539
+4,729
+3% +$360K 1.11% 36
2021
Q2
$14.1M Buy
180,810
+11,018
+6% +$820K 1.17% 35
2021
Q1
$12.5M Buy
169,792
+5,838
+4% +$431K 1.2% 33
2020
Q4
$12.8M Buy
163,954
+5,890
+4% +$450K 1.3% 30
2020
Q3
$12.5M Buy
158,064
+3,220
+2% +$252K 1.45% 27
2020
Q2
$11.4M Buy
154,844
+1,472
+1% +$111K 1.51% 30
2020
Q1
$11.3M Buy
153,372
+1,994
+1% +$157K 1.79% 21
2019
Q4
$13.1M Buy
151,378
+4,282
+3% +$352K 1.64% 27
2019
Q3
$11.8M Buy
147,096
+2,322
+2% +$186K 1.63% 29
2019
Q2
$11.6M Buy
144,774
+2,096
+1% +$160K 1.6% 30
2019
Q1
$10.6M Buy
142,678
+11,091
+8% +$830K 1.55% 30
2018
Q4
$9.59M Buy
131,587
+2,087
+2% +$147K 1.62% 23
2018
Q3
$8.77M Buy
129,500
+926
+0.7% +$59K 1.36% 32
2018
Q2
$7.45M Buy
128,574
+7,396
+6% +$417K 1.23% 35
2018
Q1
$6.3M Buy
121,178
+5,559
+5% +$300K 1.06% 36
2017
Q4
$6.21M Buy
115,619
+27,199
+31% +$1.51M 1.05% 36
2017
Q3
$5.4M Buy
88,420
+8,002
+10% +$485K 0.95% 38
2017
Q2
$4.92M Buy
80,418
+3,684
+5% +$224K 0.91% 40
2017
Q1
$4.65M Buy
+76,734
New +$4.66M 0.95% 38

Other funds holding MRK

Doyle Wealth Management's MRK Position: Q3 2022 in Review

Doyle Wealth Management reduced its Merck (MRK) stake by 0.62% in Q3 2022, selling an estimated $107K and leaving 191,071 shares worth $16.5M. The position accounts for 1.41% of the portfolio, ranked #22.

Doyle Wealth Management first reported a position in MRK in Q1 2017 and has held it in 23 quarters since. The position peaked at $17.5M in Q2 2022. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Doyle Wealth Management held 191,071 shares of Merck worth $16.5M as of Q3 2022.
  • Doyle Wealth Management sold 1,196 Merck shares in Q3 2022, an estimated $107K.
  • Merck made up 1.41% of Doyle Wealth Management's portfolio in Q3 2022, its #22 holding.
  • Doyle Wealth Management first reported a position in Merck in Q1 2017 and has held it in 23 quarters since.
  • Doyle Wealth Management's Merck position peaked at $17.5M in Q2 2022.
  • 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.